報價延遲最少15分鐘:2025/02/22 18:12 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
12.27 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.85/0.65
|
|
企業價值
4.56B
|
| 資產負債 |
|
每股賬面淨值
-1.14
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
91.43M
|
|
每股收益
0.21
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/02/22 18:12 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world byimproving access to proven treatments for various diseases. |